BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12379470)

  • 1. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Trp-P-2 mutagenicity by purpurin: mechanism of in vitro antimutagenesis.
    Marczylo T; Arimoto-Kobayashi S; Hayatsu H
    Mutagenesis; 2000 May; 15(3):223-8. PubMed ID: 10792014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of anthraquinone food pigments on the DNA damage induced by carcinogens in Drosophila.
    Takahashi E; Marczylo TH; Watanabe T; Nagai S; Hayatsu H; Negishi T
    Mutat Res; 2001 Sep; 480-481():139-45. PubMed ID: 11506807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
    Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
    Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
    Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
    Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
    Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
    Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
    Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T
    Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against the bacterial mutagenicity of heterocyclic amines by purpurin, a natural anthraquinone pigment.
    Marczylo TH; Hayatsu T; Arimoto-Kobayashi S; Tada M; Fujita K; Kamataki T; Nakayama K; Hayatsu H
    Mutat Res; 1999 Aug; 444(2):451-61. PubMed ID: 10521685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
    Josephy PD; Batty SM; Boverhof DR
    Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.